Effect to Helicobacter pylori eradication on patients with functional dyspepsia;Efecto del tratamiento erradicador para Helicobacter pylori en pacientes con dispepsia funcional

Revista Espanola de Enfermedades Digestivas

Volumn 100, Issue 9, 2008, Pages 532-539

  De Artaza Varasa, T ^a   Muñoz, J Valle ^a   Perez Grueso M J ^a   Vela, A García ^a   Escobedo, R Martín ^a   Merlo, R Rodríguez ^a   Boy, R Cuena ^a   Jiménez, J M Carrobles ^a  

^a HOSPITAL VIRGEN DE LA SALUD   (Spain)

Author keywords

Eradication therapy; Functional dyspepsia; Gastritis; Helicobacter pylori

Indexed keywords

AMOXICILLIN; CLARITHROMYCIN; RABEPRAZOLE; 2 [[(2 PYRIDYL)METHYL]SULFINYL]BENZIMIDAZOLE DERIVATIVE; ANTIINFECTIVE AGENT; ANTIULCER AGENT;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DYSPEPSIA; ERADICATION THERAPY; FEMALE; FOLLOW UP; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; MALE; RANDOMIZED CONTROLLED TRIAL; ADOLESCENT; AGED; GASTRITIS; MICROBIOLOGY; MIDDLE AGED; PROSPECTIVE STUDY;

2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES; ADOLESCENT; ADULT; AGED; AMOXICILLIN; ANTI-BACTERIAL AGENTS; ANTI-ULCER AGENTS; CLARITHROMYCIN; DYSPEPSIA; FEMALE; GASTRITIS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; YOUNG ADULT;

EID: 59449085020     PISSN: 11300108     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Talley NJ. Dyspepsia. Gastroenterology 2003; 125: 1219-26.
2. Caballero AM, Sofos S, Martín JL, et al. La prevalencia de la dispepsia en España. Med Clin 1994; 103: 717-24.
3. Tack J, Talley NJ, Camilleri M, et al. Functional gastroduodenal disorders. Gastroenterology 2006; 130: 1466-79.
4. Talley NJ, Vakil NB, Moayyedi P. AGA technical review on the evaluation of dyspepsia. Gastroenterology 2005; 129: 1756-80.
5. Feinle-Bisset C, Vozzo R, Horowitz M, et al. Diet, food intake and disturbed physiology in the pathogenesis of symptoms in functional dyspepsia. Am J Gastroenterol 2003; 99: 170-81.
6. Fischler B, Tack J, De Gucht V, et al. Heterogeneity of symptom pattern, psychosocial factors, and pathophysiological mechanisms in severe functional dyspepsia. Gastroenterology 2003; 124: 903-10.
7. Delgado-Aros S, Camilleri M, Cremonini F, et al. Contributions of gastric volumes and gastric emptying to meal size and postmeal symptoms in functional dyspepsia. Gastroenterology 2004; 127: 1685-94.
8. Boixeda D. Infección por Helicobacter pylori en la dispepsia funcional. En: Mearin F, editor. Dispepsia funcional: tan desconocida como frecuente. Barcelona: Doyma; 1997. p. 95-111.
9. Jaakkimainen R, Boyle E, Tudiver F. Is Helicobacter pylori associated with non-ulcer dyspepsia and will eradication improve symptoms? A meta-analysis. BMJ 1999; 319: 1040-4.
10. Glasbrenner B, Weiler S, Ellenrieder V, et al. Relationship between Helicobacter pylori infection, histological gastritis and functional dyspepsia. Hepatogastroenterol 1998; 45: 2238-43.
11. Sarnelli G, Cuomo R, Janssens J, et al. Symptom patterns and pathophysiological mechanisms in dyspeptic patients with and without Helicobacter pylori. Dig Dis Sci 2003; 2229-36.
12. Boixeda D, Gisbert JP, Martín de Argila C, et al. ¿Existe alguna relación entre la sintomatología digestiva y la infección por Helicobacter pylori? Rev Esp Enferm Dig 1995; 87: 8-14.
13. Holtmann G, Goebell H, Holtmann M, et al. Dyspepsia in healthy blood donors. Pattern of symptoms and association with Helicobacter pylori. Dig Dis Sci 1994: 1090-8.
14. Nandurkar S, Talley NJ, Xia HX, et al. Dyspepsia in the community: is Helicobacter pylori really a risk factor? J Gastroenterol Hepatol 1996; 11: A90.
15. Laheij RJF, Van Rossum LGM, Verbeek ALM, et al. Helicobacter pylori infection treatment of nonulcer dyspepsia. An analysis of meta-anlyses. J Clin Gastroenterol 2003; 36: 315-20.
16. Moayyedi P, Soo S, Deeks J, et al. Erradicación de Helicobacter pylori para la dyspepsia no ulcerosa (revisión Cochrane traducida). En: La biblioteca Cochrane plus, 2005 no 2. Oxford: Update software ltd.
17. Moayyedi P, Delaney BC, Vakil NM, et al. The efficacy of proton pump inhibitors in nonulcer dyspepsia: a systematic review and economic analysis. Gastroenterology 2004; 127: 1329-37.
18. Wang WH, Huang JQ, Zheng GF, et al. Effects of proton-pump inhibitors on functional dyspepsia: a meta-analysis of randomized placebo-controlled trials. Clin Gastroenterol Hepatol 2007; 5: 178-85.
19. Talley NJ, Stanghellini V, Heading RC, et al. Functional gastroduodenal disorders. Gut 1999; 45 (suppl II): II37-II42.
20. Kuykendall DH, Rabeneck L, Campbell CJM, et al. Dyspepsia: how should we measure? J Clin Epidemiol 1998; 51: 99-106.
21. Ruiz M, Villasante F, León F, et al. Cuestionario sobre calidad de vida asociada a dispepsia. Adaptación española y validación del cuestionario Dyspepsia related health scale. Med Clin 2001; 117: 567-73.
22. Dixon MF, Genta RM, Yardley JH, et al. Classification and grading og gastritis. The updated Sydney System. Am J Surg Pathol 1996; 20: 1161-81.
23. Suerbaum S, Michetti P. Helicobacter pylori infection. N Engl J Med 2002; 347: 1175-86.
24. Rubin CE. Are there three types of Helicobacter pylori gastritis? Gastroenterology 1997; 112: 2108-10.
25. Malfertheiner P, Megraud F, O'Morain F, et al. Current concepts in the management of Helicobacter pylori infection - The Maastricht III consensus report. Gut 2007; 56: 772-81.
26. Martín de Argila C, Boixeda D. Una sugerencia racional para el tratamiento erradicador de la infección por Helicobacter pylori. Med Clin 1999; 113: 334-6.
27. Veldhuyzen van Zanten S, Fedorak R, Lambert J, et al. Absence of symptomatic Benedit of lansoprazole, clarithromycin and amoxicillin triple therapy in eradication of Helicobacter pylori positive, functional (nonulcer) dyspepsia. Am J Gastroenterol 2003; 98: 1963-9.
28. Bruley DV, Flejou JF, Colin R, et al. There are some benefits for eradicating Helicobacter pylori in patients with nonulcer dyspepsia. Aliment Pharmacol Ther 2001; 15: 1177-85.
29. Axon A. Management of uninvestigated dispepsia: review and commentary. Gut 2002; 50 (Supl. 4): IV51-IV55.
30. Moayyedi P, Soo S, Deeks J, et al. Eradication of Helicobacter pylori for non-ulcer dyspepsia. Cochrane database of syst rev 2003; 1: CD002096.
31. Moayyedi P, Deeks J, Talley, et al. An update of the Cochrane systematic review of Helicobacter pylori eradication therapy in nonulcer dyspepsia: resolving the discrepancy between systematic reviews. Am J Gastroenterol 2003; 98: 2621-6.
32. Mazzoleni LE, Sander GB, Ott EA, et al. Clinical outcomes of eradication of Helicobacter pylori in nonulcer dyspepsia in a population with a high prevalence of infection: results of a 12-month randomized, double blind, placebo-controlled study. Dig Dis Sci 2006; 51: 89-98.
33. Koskenpato J, Färkkilä M, Sipponen P. Helicobacter pylori and different topographic types of gastritis. Treatment response after successful eradication therapy in functional dyspepsia. Scan J Gastroenterol 2002; 37: 778-84.